Skip to main content
Clinical Trials/JPRN-UMIN000050659
JPRN-UMIN000050659
Not yet recruiting
未知

Efficacy of pharmacist intervention for a patient who takes incretin modulator. - Efficacy of pharmacist intervention for a patient who takes incretin modulator.

Chiba Pharmaceutical Association0 sites60 target enrollmentApril 1, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetes mellitus
Sponsor
Chiba Pharmaceutical Association
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2023
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)A person who already running sleep guidance and exercise guidance. (2\)When if give exercise guidance, A person who occurs cardiovascular disease, retinopathy, nephropathy, neuropathy and orthopedic disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials